Use of HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells as a Potential Therapeutic for Progressive HER2-Positive Glioblastoma
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 2017
has subject area
- 1103 Clinical Sciences (FoR)
- 1109 Neurosciences (FoR)
- Neurology & Neurosurgery (Science Metrix)
published in
- Neurosurgery Journal